Description
[ CAS NO. ] 755037-03-7
[ Molecular Formula ] C21H15ClF4N4O3
[ Molecular Weight ] 482.81
[ Purity ] 99% min
[ Appearance ] White to off-white powder
[ Usage:Antitumor drugs and immunosuppressants
About Regorafenib
Regorafenib is an oral multi-kinase inhibitor which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK).
Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types.